Evidence map›Paper›PMID 31129693›Full record

Observational studyEuropean journal of nuclear medicine and molecular imaging2019

A prospective observational study on the long-term results of

Margit Szentesi, Zoltán Nagy, Pal Géher, István Papp, Willm Uwe Kampen

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. The EANM guideline for radiosynoviorthesis.European journal of nuclear medicine and molecular imaging · 2022
    Guideline
  2. Zeitschrift fur Rheumatologie · 2026
    Article
  3. Zeitschrift fur Rheumatologie · 2026
    Article
  4. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Highlights of the 26th EANM 2013 congress in Lyon: new horizons and further.European journal of nuclear medicine and molecular imaging · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Margit SzentesiDepartment of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God Budapest, Semmelweis University, Budapest, Hungary.
Zoltán NagyDepartment of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God Budapest, Semmelweis University, Budapest, Hungary.
Pal GéherDepartment of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God Budapest, Semmelweis University, Budapest, Hungary.
István PappDepartment of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God Budapest, Semmelweis University, Budapest, Hungary.
Willm Uwe KampenNuclear Medicine Spitalerhof, Hamburg, Germany. kampen@nuklearmedizin-spitalerhof.de.ORCID http://orcid.org/0000-0002-3500-9713
Semmelweis University · HUSpitäler Schaffhausen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesRadiosynoviorthesis (RSO) is used for the treatment of inflammatory joint diseases. However, there are no long-term results published comparing it to conservative therapy. Therefore, the aim of this prospective observational study was to evaluate response rates after radionuclide therapy in patients suffering from knee osteoarthritis over a time period of 10 years.

methodsRadionuclide therapy with intra-articular administration of colloidal

resultsIn patients with early-stage disease, an excellent/good response with respect to pain, joint mobility, and function was observed in 82.5% for 1 year and in 73.7% for 8 years after therapy. Responses declined to 50% at 10 years post treatment. In grade III patients, an excellent/good response was observed in 45.9%; a decline to 41.2% was observed in the first 8 years. In this group, the number of patients available for follow-up after 9 and 10 years dropped significantly from 51 patients after 8 years to only 30 patients after 9 years, and to nine patients after 10 years. As a result, these response rates were not appraisable.

conclusionLong-term results of radiosynoviorthesis in knee osteoarthritis are excellent/good in many patients. The response rate depends on Kellgren-Lawrence stages, and early-stage radionuclide therapy for osteoarthritis is suggested.

Indexed as

AdultAgedCitratesFemaleHumansLong Term Adverse EffectsMaleMiddle AgedOrganometallic CompoundsOsteoarthritis, KneeRadiopharmaceuticalsSynovitisCitratesOrganometallic CompoundsRadiopharmaceuticalsyttrium citrate90Yttrium citrateIntra-articular radionuclide therapyOsteoarthritisRadiosynoviorthesis

Identifiers

PMID31129693
OpenAlexW2946508038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.